Keywords: Placenta, fMRI, Gestational hypertension, perfusion, placenta, virtual magnetic resonance elastography
Motivation: Detecting placental dysfunction using MRI before placental macrovascular lesions by ultrasound may help the early identification of placental pathologic changes in gestational hypertension (GH).
Goal(s): To explore changes in placental elasticity and perfusion in GH and control groups using MRI.
Approach: Placental elasticity and perfusion were assessed using virtual magnetic resonance elastography (vMRE) and intravoxel incoherent motion (IVIM). The vMRE and IVIM parameters, MR morphologic parameters, and ultrasound and lab test results were compared between the two groups.
Results: Placental stiffness and perfusion fraction helped distinguish between the two groups, with no substantial differences in the other parameters.
Impact: Virtual magnetic resonance elastography and intravoxel incoherent motion can quantify placental elasticity and circulation at the microscopic level, and are superior to the ultrasound parameters, in gestational hypertension. They may serve as a vital noninvasive supplement to assess placental dysfunction.
This study was financially supported by the Young Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University (PY2021002).
2. Wu P, Green M, Myers JE. Hypertensive disorders of pregnancy. BMJ 2023; 381:e71653.
3. Papageorghiou AT, Yu CK, Cicero S, Bower S, Nicolaides KH. Second-trimester uterine artery Doppler screening in unselected populations: a review. J Matern Fetal Neonatal Med 2002; 12:78-88.
4. Le Bihan D. What can we see with IVIM MRI? Neuroimage 2019; 187:56-67.
5. Le Bihan D, Ichikawa S, Motosugi U. Diffusion and Intravoxel Incoherent Motion MR Imaging-based Virtual Elastography: A Hypothesis-generating Study in the Liver. Radiology 2017; 285:609-619.
6. Deng J, Cao Y, Lu Y, et al. Value of placental virtual magnetic resonance elastography and intravoxel incoherent motion-based diffusion and perfusion in predicting adverse outcomes of small-for-gestational-age infants. Insights Imaging 2023; 14:153.
7. Kromrey ML, Le Bihan D, Ichikawa S, Motosugi U. Diffusion-weighted MRI-based Virtual Elastography for the Assessment of Liver Fibrosis. Radiology 2020; 295:127-135.
8. Chen T, Zhao M, Song J, et al. The effect of maternal hyperoxygenation on placental perfusion in normal and Fetal Growth Restricted pregnancies using Intravoxel Incoherent Motion. Placenta 2019; 88:28-35.
9. Deng J, Zhang A, Zhao M, et al. Placental perfusion using intravoxel incoherent motion MRI combined with Doppler findings in differentiating between very low birth weight infants and small for gestational age infants. Placenta 2023; 135:16-24.
10. Siauve N, Hayot PH, Deloison B, et al. Assessment of human placental perfusion by intravoxel incoherent motion MR imaging. J Matern Fetal Neonatal Med 2019; 32:293-300.
11. Hernandez-Andrade E, Huntley ES, Bartal MF, et al. Doppler evaluation of normal and abnormal placenta. Ultrasound Obstet Gynecol 2022; 60:28-41.
12. Chang KJ, Seow KM, Chen KH. Preeclampsia: Recent Advances in Predicting, Preventing, and Managing the Maternal and Fetal Life-Threatening Condition. Int J Environ Res Public Health 2023; 20.
13. Jahan F, Vasam G, Green AE, Bainbridge SA, Menzies KJ. Placental Mitochondrial Function and Dysfunction in Preeclampsia. Int J Mol Sci 2023; 24.
14. Haeussner E, Schmitz C, von Koch F, Frank HG. Birth weight correlates with size but not shape of the normal human placenta. Placenta 2013; 34:574-582.
Figure 1. Framework of the study.
CPR, cerebroplacental ratio; μdiff, diffusion-weighted imaging–based shear modulus; D, true diffusion coefficient; D*, pseudo-diffusion coefficient; f, perfusion fraction; IVIM, intravoxel incoherent motion; MCA, middle cerebral artery; PI, pulsatility index; RI, resistance index; ROC, receiver-operating characteristic; ROI, region of interest; S/D, peak systolic velocity/end-diastolic velocity; UA, umbilical arterial; vMRE, virtual magnetic resonance elastography.
Table 1. Comparison of demographic and clinical data between GH and control groups
GA, Gestational age; GH, gestational hypertension; MRI, magnetic resonance imaging; PE, preeclampsia.
Table 2. Comparison parameters between GH and control groups
ALT, alanine aminotransferase; AST, aspartate aminotransferase; CPR, cerebroplacental ratio; μdiff, diffusion-weighted imaging–based shear modulus; D, true diffusion coefficient; D*, pseudo-diffusion coefficient; f, perfusion fraction; MCA, middle cerebral artery; PI, pulsatility index; PT, prothrombin time; RI, resistance index; S/D, peak systolic velocity/end-diastolic velocity; TB, total bile acid; UA, umbilical arterial; vMRE, virtual magnetic resonance elastography.
Figure 2. Box plots of µdiff, D, f, ADC, and PT for GH and control groups.
ADC, apparent diffusion coefficient; μdiff, diffusion-weighted imaging–based shear modulus; D, true diffusion coefficient; f, perfusion fraction; GH, gestational hypertension; PT, prothrombin time.
Figure 3. ROC curves for differentiating GH groups from control groups.
ADC, apparent diffusion coefficient; μdiff, diffusion-weighted imaging–based shear modulus; D, true diffusion coefficient; f, perfusion fraction; PT, prothrombin time; ROC, receiver-operating characteristic.